GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 711 filers reported holding GLAXOSMITHKLINE PLC in Q3 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $208,000 | -15.8% | 5,825 | -13.4% | 0.00% | -25.0% |
Q4 2020 | $247,000 | -2.4% | 6,725 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $253,000 | -7.7% | 6,725 | 0.0% | 0.00% | -33.3% |
Q2 2020 | $274,000 | +5.0% | 6,725 | -2.2% | 0.01% | -25.0% |
Q1 2020 | $261,000 | -19.2% | 6,876 | 0.0% | 0.01% | -11.1% |
Q4 2019 | $323,000 | +10.2% | 6,876 | 0.0% | 0.01% | +12.5% |
Q3 2019 | $293,000 | +6.5% | 6,876 | 0.0% | 0.01% | -11.1% |
Q2 2019 | $275,000 | -4.2% | 6,876 | 0.0% | 0.01% | 0.0% |
Q1 2019 | $287,000 | +9.1% | 6,876 | 0.0% | 0.01% | -10.0% |
Q4 2018 | $263,000 | -4.7% | 6,876 | 0.0% | 0.01% | +11.1% |
Q3 2018 | $276,000 | -0.4% | 6,876 | 0.0% | 0.01% | -10.0% |
Q2 2018 | $277,000 | +3.0% | 6,876 | 0.0% | 0.01% | -9.1% |
Q1 2018 | $269,000 | -1.1% | 6,876 | -10.4% | 0.01% | 0.0% |
Q4 2017 | $272,000 | -28.6% | 7,676 | -18.1% | 0.01% | -35.3% |
Q3 2017 | $381,000 | -5.7% | 9,376 | 0.0% | 0.02% | -5.6% |
Q2 2017 | $404,000 | +2.3% | 9,376 | 0.0% | 0.02% | 0.0% |
Q1 2017 | $395,000 | -13.2% | 9,376 | -20.7% | 0.02% | -21.7% |
Q4 2016 | $455,000 | +19.4% | 11,826 | +34.0% | 0.02% | +15.0% |
Q3 2016 | $381,000 | -0.5% | 8,826 | 0.0% | 0.02% | -4.8% |
Q2 2016 | $383,000 | +7.0% | 8,826 | 0.0% | 0.02% | -4.5% |
Q1 2016 | $358,000 | -3.0% | 8,826 | -3.7% | 0.02% | -4.3% |
Q4 2015 | $369,000 | +4.8% | 9,167 | 0.0% | 0.02% | 0.0% |
Q3 2015 | $352,000 | -7.9% | 9,167 | 0.0% | 0.02% | -8.0% |
Q2 2015 | $382,000 | -9.7% | 9,167 | 0.0% | 0.02% | -10.7% |
Q1 2015 | $423,000 | -22.4% | 9,167 | -28.1% | 0.03% | -22.2% |
Q4 2014 | $545,000 | -9.8% | 12,756 | -3.0% | 0.04% | -14.3% |
Q3 2014 | $604,000 | -12.1% | 13,146 | +2.3% | 0.04% | -14.3% |
Q2 2014 | $687,000 | +10.1% | 12,846 | +10.0% | 0.05% | -2.0% |
Q1 2014 | $624,000 | +13.9% | 11,679 | +13.8% | 0.05% | -9.1% |
Q4 2013 | $548,000 | -12.7% | 10,259 | -18.0% | 0.06% | -24.7% |
Q3 2013 | $628,000 | +0.5% | 12,509 | 0.0% | 0.07% | -13.1% |
Q2 2013 | $625,000 | – | 12,509 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |